Journal profile
STEMedicine
ISSN 2705-1188 · Innovation Publishing House Pte. Ltd. · Singapore
STEMedicine: fully open access; APC about USD 1,200; review about 6 weeks (community reports); 0 articles in 2025.
Scope
Aims, scope and focus
STEMedicine is published by Innovation Publishing House Pte. Ltd.. By OpenAlex counts of its recent articles, its largest topics are MicroRNA in disease regulation, Mesenchymal stem cell research and Cancer-related molecular mechanisms research, together about 25.6% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
STEMedicine (ISSN Online: 2705-1188) is an international, peer-reviewed, open-access journal published by Innovation Publishing House Pte. Ltd., Singapore. Established in 2020, the journal is dedicated to advancing knowledge across the broad field of medical sciences by publishing high-quality, original, and evidence-based research. The journal provides a global platform for researchers, clinicians, healthcare professionals, educators, and policymakers to disseminate scientific discoveries that improve clinical practice, healthcare delivery, biomedical innovation, and public health. STEMedicine welcomes contributions from authors worldwide and promotes interdisciplinary collaboration to address emerging challenges in medicine and healthcare. The journal publishes original research articles, systematic reviews, meta-analyses, clinical studies, case reports, short communications, review articles, editorials, perspectives, and letters to the editor. All submitted manuscripts undergo a rigorous double-blind peer-review process conducted by independent experts to ensure scientific quality, originality, ethical integrity, and relevance. STEMedicine is committed to the principles of open access, enabling unrestricted, immediate, and permanent access to published research without subscription barriers. The journal supports transparency, research integrity, ethical publishing practices, and the global dissemination of scientific knowledge to advance healthcare and medical research.
From the journal's Aims & Scope
Editor-in-chief Vincent TorrePublisher website
Editorial board by country: none in mainland China; most named Pakistan 2, Italy 1, Singapore 1, Croatia 1 (5 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology10.3%
- Mesenchymal stem cell researchMedicine9%
- Cancer-related molecular mechanisms researchBiochemistry, Genetics and Molecular Biology6.4%
- Neuroscience and Neuropharmacology ResearchNeuroscience5.1%
- Cancer Cells and MetastasisMedicine5.1%
- Neurogenesis and neuroplasticity mechanismsNeuroscience5.1%
- Advanced Neural Network ApplicationsComputer Science3.9%
- Alzheimer's disease research and treatmentsMedicine3.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
DOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- h-index
- 12OpenAlex ·
- i10-index
- 16OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 81 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 2 | 2 | 12 |
| 2025 | 0 | 0 | 37 |
| 2024 | 1 | 1 | 52 |
| 2023 | 18 | 18 | 107 |
| 2022 | 20 | 20 | 128 |
| 2021 | 12 | 12 | 122 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 6 weeksLetPub ·
- Submission to publication (journal-reported)
- about 6 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 1,200 | Yes | CC BY | |
| OpenAlex | USD 1,200 | — | — | |
| LetPub | USD 1,200 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Innovation Publishing House Pte. Ltd.
- Country or region
- Singapore
- Language
- English
- ISSN
- 2705-1188
- Latest issue on the website
- Volume 7, Issue 1 (2026)
- Official links
- Journal homepage ↗DOAJ
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about STEMedicine
How long does peer review take at STEMedicine?
Authors report an average review time of about 6 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of STEMedicine based?
Of the 5 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Pakistan (2), Italy (1) and Singapore (1). Counted from the institutions listed on the board page; for reference only.
Which databases index STEMedicine?
According to LetPub and DOAJ records, STEMedicine is indexed in DOAJ.
Is STEMedicine open access, and what is the APC?
STEMedicine is a fully open-access journal. APC about USD 1,200.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .